Joachim co-founded sterna biologicals in 2006 and is a Managing Director of the company.

His extensive experience in the life science space includes having co-founded a biotech company that was subsequently acquired by an international healthcare company as well as a medtech company and an innovation centre which both continue to operate profitably.

Prior to joining sterna biologicals, Joachim was responsible for the life science business of a start-up incubator.

He received his PhD in biology from the Justus Liebig University in Giessen.

BA, MA               Jonas Renz
Managing Director

Jonas joined sterna biologicals in 2011 and is a Managing Director of the company.

Prior to joining sterna biologicals, he held various positions with investment management firms.

After graduating from Oxford University, Jonas joined Goldman Sachs’ Principal Investment Area in London, where he worked on a number of private equity transactions for the Goldman Sachs Capital Partners family of funds. In 2006, he moved to Och-Ziff Capital Management in London, where his responsibilities included special situations and equity long/short investments. In 2009, he founded an investment management company in Berlin.

Diplom-Molekularmedizinerin
Ursula Homburg
Head of Research & Deveopment

Ursula joined sterna biologicals in 2011 to lead the company’s R&D activities.

She has considerable experience in immunology, oncology, drug development, and regulatory affairs. Her previous professional career includes heading the newly-founded Centre of Oncology in Kassel and working on the development of therapeutic antibodies with U3 Pharma AG in Martinsried.

Ursula received her diploma in molecular medicine from the University of Erlangen-Nürnberg and wrote her diploma thesis at the UniSpital Zurich (Division of Immunology).